Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Displaying drugs 1 - 25 of 7123 in total

Meningococcal polysaccharide vaccine group A

Meningococcal group A polysaccharide is group-specific polysaccharide antigens extracted and purified from Neisseria meningitidis serogroup A. N. meningitidis is a bacteria that causes endemic and epidemic diseases including meningitis and meningococcemia. It is subcutaneously administered as an active immunization against the invasive meningococcal disease caused by the serogroup A.
Approved
Experimental
Investigational
Matched Synonyms: … Meningococcal group A polysaccharide ... Meningococcal polysaccharide antigen group A ... Neisseria meningitidis group A polysaccharide antigen, A …
Matched Name: … Meningococcal polysaccharide vaccine group A …
Matched Description: … Meningococcal group A polysaccharide is group-specific polysaccharide antigens extracted and purified …

Meningococcal polysaccharide vaccine group C

Meningococcal group C polysaccharide is group-specific polysaccharide antigens extracted and purified from Neisseria meningitidis serogroup C. N. meningitidis is a bacteria that causes endemic and epidemic diseases including meningitis and meningococcemia. It is subcutaneously administered as an active immunization against the invasive meningococcal disease caused by the serogroup C.
Approved
Experimental
Investigational
Matched Synonyms: … Meningococcal group C polysaccharide ... Meningococcal group CCRM197 conjugate vaccine ... Meningococcal polysaccharide antigen group C …
Matched Name: … Meningococcal polysaccharide vaccine group C …
Matched Description: … Meningococcal group C polysaccharide is group-specific polysaccharide antigens extracted and purified …

Meningococcal polysaccharide vaccine group W-135

Meningococcal group W-135 polysaccharide is group-specific polysaccharide antigens extracted and purified from Neisseria meningitidis serogroup W-135. N. meningitidis is a bacteria that causes endemic and epidemic diseases including meningitis and meningococcemia. It is subcutaneously administered as an active immunization against the invasive meningococcal disease caused by the serogroup W-135.
Approved
Experimental
Investigational
Matched Synonyms: … Meningococcal polysaccharide antigen group W-135 ... Neisseria meningitidis group W-135 polysaccharide antigen, A ... neisseria meningitidis group W-135 capsular polysaccharide antigen …
Matched Name: … Meningococcal polysaccharide vaccine group W-135 …
Matched Description: … Meningococcal group W-135 polysaccharide is group-specific polysaccharide antigens extracted and purified …

Neisseria meningitidis group Y capsular polysaccharide tetanus toxoid conjugate antigen

Approved
Matched Synonyms: … Nimenrix component neisseria meningitidis group Y capsular polysaccharide tetanus toxoid conjugate antigen …
Matched Name: … Neisseria meningitidis group Y capsular polysaccharide tetanus toxoid conjugate antigen …

Neisseria meningitidis group a capsular polysaccharide diphtheria toxoid conjugate antigen

Neisseria meningitidis group a capsular polysaccharide diphtheria toxoid conjugate antigen is an active intramuscular immunization for the prophylaxis of invasive meningococcal disease caused by Neisseria meningitidis serogroup a. The vaccine contains N. meningitis serogroup a capsular polysaccharide antigens that are purified and individually conjugated to diphtheria toxoid protein that are...
Approved
Investigational
Matched Name: … Neisseria meningitidis group a capsular polysaccharide diphtheria toxoid conjugate antigen …
Matched Description: … Neisseria meningitidis group a capsular polysaccharide diphtheria toxoid conjugate antigen is an active …

Neisseria meningitidis group y capsular polysaccharide diphtheria toxoid conjugate antigen

Neisseria meningitidis group y capsular polysaccharide diphtheria toxoid conjugate antigen is an active intramuscular immunization for the prophylaxis of invasive meningococcal disease caused by Neisseria meningitidis serogroup W-135. The vaccine contains* N. meningitis* serogroup y capsular polysaccharide antigens that are purified and individually conjugated to diphtheria toxoid protein that are...
Approved
Matched Name: … Neisseria meningitidis group y capsular polysaccharide diphtheria toxoid conjugate antigen …
Matched Description: … Neisseria meningitidis group y capsular polysaccharide diphtheria toxoid conjugate antigen is an active …

Neisseria meningitidis group a capsular oligosaccharide diphtheria crm197 protein conjugate antigen

Neisseria meningitidis group a capsular oligosaccharide diphtheria crm197 protein conjugate antigen is a vaccine.
Approved
Matched Name: … Neisseria meningitidis group a capsular oligosaccharide diphtheria crm197 protein conjugate antigen …
Matched Description: … Neisseria meningitidis group a capsular oligosaccharide diphtheria crm197 protein conjugate antigen is …

Neisseria meningitidis group w-135 capsular polysaccharide diphtheria toxoid conjugate antigen

Neisseria meningitidis group w-135 capsular polysaccharide diphtheria toxoid conjugate antigen is an active intramuscular immunization for the prophylaxis of invasive meningococcal disease caused by Neisseria meningitidis serogroup W-135. The vaccine contains N. meningitis serogroup W-135 capsular polysaccharide antigens that are purified and individually conjugated to diphtheria toxoid protein that are...
Approved
Matched Name: … Neisseria meningitidis group w-135 capsular polysaccharide diphtheria toxoid conjugate antigen …
Matched Description: … Neisseria meningitidis group w-135 capsular polysaccharide diphtheria toxoid conjugate antigen is an …

AstraZeneca COVID-19 Vaccine

The AstraZeneca COVID-19 Vaccine (previously known as ChAdOx1 nCoV-19 or AZD1222) is one of several vaccines developed in 2020 for the prevention of COVID-19 caused by SARS-CoV-2.[L12669,L32649] The ChAdOx1 viral vector was developed at the University of Oxford and has been investigated as a potential vector for vaccines against another...
Approved
Investigational
Matched Synonyms: … AZD-1222 …

Talquetamab

Talquetamab is a IgG4-PAA bispecific G protein-coupled receptor class C group 5 member D (GPRC5D)-directed CD3 T-cell engager. It consists of two arms - anti-GPRC5D and anti-CD3 arms - linked by two interchain disulfide bonds, each arm comprising a heavy and light chain. Talquetamab binds to GPRC5D, a cell surface...
Approved
Investigational
Matched Synonyms: … IMMUNOGLOBULIN G4-KAPPA/G4-LAMBDA, ANTI-(HOMO SAPIENS GPRC5D (G PROTEIN-COUPLED RECEPTOR CLASS C GROUP ... IMMUNOGLOBULIN G4-KAPPA/G4-LAMBDA, ANTI-(HOMO SAPIENS GPRC5D (G PROTEIN-COUPLED RECEPTOR CLASS C GROUP …
Matched Description: … [L47775] Talquetamab was fully approved by the EMA on August 22, 2023. ... Talquetamab is a IgG4-PAA bispecific G protein-coupled receptor class C group 5 member D (GPRC5D)-directed …

Plasma protein fraction (human)

The plasma protein fraction human (PPFh) is defined as a sterile solution of proteins composed mainly of albumin and globulin derived from human plasma. It is already reviewed under the category of biologics by the FDA where the processing, required tests, requirements and labeling are incorporated. This biologic should come...
Approved
Matched Description: … [A32512] It is already reviewed under the category of biologics by the FDA where the processing, required …
Matched Products: … OCTAPLAS Blood Group A ... OCTAPLAS Blood Group O ... OCTAPLAS Blood Group B …

Acenocoumarol

Acenocoumarol is a coumarin derivative used as an anticoagulant. Coumarin derivatives inhibit the reduction of vitamin K by vitamin K reductase. This prevents carboxylation of vitamin K-dependent clotting factors, II, VII, IX and X, and interferes with coagulation. Hematocrit, hemoglobin, international normalized ratio and liver panel should be monitored. Patients...
Approved
Investigational
Matched Products: … Truemed Group LLC …

Fludrocortisone

Fludrocortisone is a synthetic mineralocorticoid used in conjunction with hydrocortisone to replace missing endogenous corticosteroids in patients with adrenal insufficiency.[A187169,A187187] It is functionally similar to aldosterone, the body's primary endogenous mineralocorticoid, and is structurally analogous to cortisol, differing only by a fluorine atom at the 9-position of the steroid structure...
Approved
Investigational
Matched Products: … Truemed Group LLC …

Orciprenaline

A beta-adrenergic agonist used in the treatment of asthma and bronchospasms. [PubChem]
Approved
Matched Products: … Truemed Group LLC …

Revefenacin

Revefenacin is a novel biphenyl carbamate tertiary amine agent that belongs to the family of the long-acting muscarinic antagonists (LAMA). The labile primary amide in the structure produces a "soft-drug" site that allows rapid systemic clearance and minimizing of the systemically mediated adverse reactions. The LAMA group falls into a...
Approved
Investigational
Matched Description: … The LAMA group falls into a parent category known as long-acting inhaled bronchodilators and this type ... [A40026] It was developed by Theravance Biopharma and FDA approved on November 9, 2018.[L4818] ... Revefenacin is a novel biphenyl carbamate tertiary amine agent that belongs to the family of the long-acting …

Ioxilan

Ioxilan is a tri-iodinated diagnostic contrast agent. Intravascular injection results in opacification of vessels in the path of flow of the contrast medium, permitting radiographic visualization of the internal structures of the human body until significant hemodilution occurs.
Approved
Matched Description: … Ioxilan is a tri-iodinated diagnostic contrast agent. …
Matched Categories: … Radiographic Contrast Agent …

Digoxin

Digoxin is one of the oldest cardiovascular medications used today. It is a common agent used to manage atrial fibrillation and the symptoms of heart failure. Digoxin is classified as a cardiac glycoside and was initially approved by the FDA in 1954. This drug originates from the foxglove plant, also...
Approved
Matched Description: … [A178225] It is a common agent used to manage atrial fibrillation and the symptoms of heart failure. ... [A178234] Digoxin is classified as a cardiac glycoside and was initially approved by the FDA in 1954. …
Matched Products: … Truemed Group LLC …

Teriparatide

Teriparatide is a recombinant parathyroid hormone (PTH) analog and a potent osteoanabolic agent. It is made up of the first amino(N)-terminal 34 amino acids of the human PTH. First approved in the United States in November 2002 and in Europe in April 2003, teriparatide makes the first approved drug in...
Approved
Investigational
Matched Description: … teriparatide makes the first approved drug in a new category of osteoporosis therapy called anabolic ... Teriparatide is a recombinant parathyroid hormone (PTH) analog and a potent osteoanabolic agent. ... [A251395] First approved in the United States in November 2002 and in Europe in April 2003,[A251400] …

Technetium Tc-99m oxidronate

Technetium Tc-99m oxidronate, also known as 99mTc-methylene diphosphonate, is a radiopharmaceutical agent. A radiopharmaceutical is defined as a medicinal formulation containing radioisotopes that are used in major clinical areas for diagnosis and/or therapy. The radiopharmaceuticals based on technetium-99m are widely used for diagnostic purposes because 99mTc has a versatile chemistry...
Approved
Matched Description: … The group oxidronate falls into the category of diphosphonates whose structure allows them to bind to ... [L1140] It was developed by Mallinkrodt nuclear and FDA approved on February 18, 1981. ... Technetium Tc-99m oxidronate, also known as 99mTc-methylene diphosphonate, is a radiopharmaceutical agent …
Matched Categories: … Radioactive Diagnostic Agent …

Casirivimab

Casirivimab is a monoclonal antibody combined with Imdevimab in Regeneron's antibody cocktail known as REGN-COV2 for the treatment of COVID-19. This drug is a combination of antibodies derived from humanized VelocImmune® mice in addition to blood samples from patients who have recovered from COVID-19. These antibodies have been formulated to...
Approved
Experimental
Matched Description: … [L23524] In November 2021, the same indication was approved by the EMA. ... investigational recombinant human IgG1 monoclonal antibodies that, at this time, are not officially approved …
Matched Categories: … Approved Treatments for COVID-19 …

Hyoscyamine

Hyoscyamine is a tropane alkaloid and the levo-isomer of atropine. It is commonly extracted from plants in the Solanaceae or nightshade family. Research into the action of hyoscyamine in published literature dates back to 1826. Hyoscyamine is used for a wide variety of treatments and therapeutics due to its antimuscarinic...
Approved
Matched Description: … [L31548,L31553] Although hyoscyamine is marketed in the United States, it is not FDA approved. …

Ferric sulfate

Ferric sulfate has the molecular formula of Fe2SO4, and it is a dark brown or yellow chemical agent with acidic properties. It is produced by the reaction of sulfuric acid and an oxidizing agent. It is used in different fields such as dermatology, dentistry and it is thought to present...
Approved
Matched Description: … [A32355, A32356] By the FDA, ferric sulfate is a direct food substance affirmed in the GRAS category ... It is produced by the reaction of sulfuric acid and an oxidizing agent. ... Ferric sulfate has the molecular formula of Fe2SO4, and it is a dark brown or yellow chemical agent with …

Triclosan

An aromatic ether that is phenol which is substituted at C-5 by a chloro group and at C-2 by a 2,4-dichlorophenoxy group. It is widely used as a preservative and antimicrobial agent in personal care products such as soaps, skin creams, toothpaste and deodorants as well as in household items...
Approved
Investigational
Matched Description: … group. ... It is widely used as a preservative and antimicrobial agent in personal care products such as soaps, ... An aromatic ether that is phenol which is substituted at C-5 by a chloro group and at C-2 by a 2,4-dichlorophenoxy …
Matched Products: … Chinese Herb Essence Bacteriostatic Foaming Agent …

Meradimate

Meradimate, before known as menthyl anthranilate, is used in a maximal concentration of 5% in different products as a UV filter. It is currently required to be named as meradimate in all FDA approved OTC products. Meradimate is approved by the FDA and Health Canada to be used as an...
Approved
Matched Description: … [T200] It is currently required to be named as meradimate in all FDA approved OTC products. ... Meradimate is approved by the FDA and Health Canada to be used as an ingredient in sunblocking products …

Ivermectin

Ivermectin is a semi-synthetic antiparasitic medication derived from avermectins, a class of highly-active broad-spectrum antiparasitic agents isolated from the fermentation products of Streptomyces avermitilis. Ivermectin itself is a mixture of two avermectins, comprising roughly 90% 5-O-demethyl-22,23-dihydroavermectin A1a (22,23-dihydroavermectin B1a) and 10% 5-O-demethyl-25-de(1-methylpropyl)-22,23-dihydro­-25-(1-methylethyl)avermectin A1a (22,23-dihydroavermectin B1b). Ivermectin is mainly used in...
Approved
Investigational
Vet approved
Displaying drugs 1 - 25 of 7123 in total